Skip to content
  • Sunday, 31 May 2026
  • 12:57 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels

Dwi Wanna May 12, 2026 0

In a breakthrough study published in the Journal of Clinical Investigation, researchers from the University of Michigan and the University…

Read More
Biotech & Genetic Research

Groundbreaking Research Uncovers How Cellular Tunnels Drive Huntington’s Disease Progression, Revealing Novel Therapeutic Avenue

Jia Lissa May 8, 2026 0

A recent scientific breakthrough, spearheaded by a team of researchers from Florida Atlantic University (FAU), has fundamentally reshaped our understanding…

Read More
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels

Dwi Wanna May 4, 2026 0

Researchers from the University of Michigan and the University of California San Diego have published a groundbreaking study identifying the…

Read More
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.

Dwi Wanna Apr 27, 2026 0

This fundamental discovery, detailed in a collaborative study by researchers from the University of Michigan and the University of California…

Read More
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels

Dwi Wanna Apr 6, 2026 0

The persistence of estrogen receptor-positive (ER+) breast cancer remains one of the most formidable challenges in modern oncology, as patients…

Read More
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels

Dwi Wanna Mar 23, 2026 0

The phenomenon of cancer recurrence remains one of the most significant challenges in modern oncology, particularly in the context of…

Read More
Mitochondrial Dysfunction Identified as Direct Cause of Dementia Symptoms in Breakthrough StudyScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Gravitational Waves from Colliding Black Holes May Reveal the Secret of Dark MatterA strange new quantum state appears when atoms get “frustrated”
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data PlatformCBD Shows Promise in Mitigating Neuroinflammation and Targeting Alzheimer’s Disease ProgressionUnprecedented Observation of Doubly Ring-Slipped Intermediates Provides New Insights into the Formation and Structural Dynamics of MetallocenesAbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer Drug
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
Lana Keisha May 31, 2026
Neuroscience & Brain Research
CBD Shows Promise in Mitigating Neuroinflammation and Targeting Alzheimer’s Disease Progression
Rifan Muazin May 31, 2026
Advanced Materials Science
Unprecedented Observation of Doubly Ring-Slipped Intermediates Provides New Insights into the Formation and Structural Dynamics of Metallocenes
Nila Kartika Wati May 31, 2026
Pharmaceutical R&D
AbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer Drug
Teuku Ryan May 31, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ